These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 8827085

  • 1. Clinical study on estramustine binding protein (EMBP) in human prostate.
    Shiina H, Igawa M, Ishibe T.
    Prostate; 1996 Sep; 29(3):169-76. PubMed ID: 8827085
    [Abstract] [Full Text] [Related]

  • 2. Estramustine-binding protein to dihydrotestosterone ratio in human prostatic carcinoma: a new marker for predicting disease progression.
    Shiina H, Igawa M, Ishibe T.
    Br J Urol; 1996 Jan; 77(1):96-101. PubMed ID: 8653325
    [Abstract] [Full Text] [Related]

  • 3. Estramustine-binding protein in carcinoma and benign hyperplasia of the human prostate.
    Shiina H, Urakami S, Shirakawa H, Igawa M, Ishibe T, Usui T.
    Eur Urol; 1996 Jan; 29(1):106-10. PubMed ID: 8821700
    [Abstract] [Full Text] [Related]

  • 4. Study of estramustine binding protein: its relationship to androgen dependency and histological differentiation in human prostatic carcinoma tissue.
    Shiina H, Sumi H, Ishibe T, Usui T.
    Urol Int; 1994 Jan; 52(4):213-6. PubMed ID: 8030169
    [Abstract] [Full Text] [Related]

  • 5. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.
    Ho PJ, Baxter RC.
    Clin Endocrinol (Oxf); 1997 Feb; 46(2):145-54. PubMed ID: 9135695
    [Abstract] [Full Text] [Related]

  • 6. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.
    Ho PJ, Baxter RC.
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):333-42. PubMed ID: 9156044
    [Abstract] [Full Text] [Related]

  • 7. Immunohistochemical analysis of estramustine binding protein with particular reference to proliferative activity in human prostatic carcinoma.
    Shiina H, Igawa M, Shigeno K, Wada Y, Yoneda T, Shirakawa H, Ishibe T, Shirakawa R, Nagasaki M, Shirane T, Usui T.
    Prostate; 1997 Jun 15; 32(1):49-58. PubMed ID: 9207957
    [Abstract] [Full Text] [Related]

  • 8. Estramustine-binding protein--a marker for effect of therapy in prostatic carcinoma?
    Björk PA, Flüchter SH, Nelde HJ.
    Scand J Urol Nephrol Suppl; 1988 Jun 15; 107():59-64. PubMed ID: 3287599
    [Abstract] [Full Text] [Related]

  • 9. Estramustine binding protein in human benign prostatic hypertrophy.
    Shiina H, Mizutani M, Ishibe T.
    Andrologia; 1990 Jun 15; 22(4):309-12. PubMed ID: 1702270
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of MENT on primary cell cultures from benign prostatic hyperplasia and prostate carcinoma.
    Mendoza P, Sánchez C, Contreras HR, Vergara J, Acevedo C, Cabezas J, Huidobro C, Noé G, Castellón EA.
    Int J Androl; 2009 Dec 15; 32(6):607-15. PubMed ID: 18637152
    [Abstract] [Full Text] [Related]

  • 11. Androgens and estrogens: their interaction with stroma and epithelium of human benign prostatic hyperplasia and normal prostate.
    Krieg M, Bartsch W, Thomsen M, Voigt KD.
    J Steroid Biochem; 1983 Jul 15; 19(1A):155-61. PubMed ID: 6193338
    [Abstract] [Full Text] [Related]

  • 12. Relationship of thyroid to estramustine binding protein (EMBP) concentration in rat prostate.
    Shiina H, Sumi H, Ishibe T, Usui T.
    Andrologia; 1991 Jul 15; 23(2):145-9. PubMed ID: 1952120
    [Abstract] [Full Text] [Related]

  • 13. Effect of treatment on the expression of estramustine-binding protein (EMBP) in prostatic cancer patients: an immunohistochemical study.
    Flüchter SH, Nelde HJ, Björk P, Müntzing J, Bichler KH.
    Prostate; 1989 Jul 15; 14(1):27-43. PubMed ID: 2648345
    [Abstract] [Full Text] [Related]

  • 14. Partial characterization and "quantitation" of a human prostatic estramustine-binding protein.
    Björk P, Forsgren B, Gustafsson JA, Pousette A, Högberg B.
    Cancer Res; 1982 May 15; 42(5):1935-42. PubMed ID: 7066904
    [Abstract] [Full Text] [Related]

  • 15. Differential uptake of estramustine phosphate metabolites and its correlation with the levels of estramustine binding protein in prostate tumor tissue.
    Walz PH, Björk P, Gunnarsson PO, Edman K, Hartley-Asp B.
    Clin Cancer Res; 1998 Sep 15; 4(9):2079-84. PubMed ID: 9748122
    [Abstract] [Full Text] [Related]

  • 16. Estramustine-binding protein and specific binding of the anti-mitotic compound estramustine in astrocytoma.
    Bergenheim AT, Björk P, Bergh J, von Schoultz E, Svedberg H, Henriksson R.
    Cancer Res; 1994 Sep 15; 54(18):4974-9. PubMed ID: 8069865
    [Abstract] [Full Text] [Related]

  • 17. Elevated expression of estramustine binding protein (EMBP) in prostatic intraepithelial neoplasia (PIN) compared with malignant and benign prostatic epithelia.
    de la Torre M, Eklöv S, Häggman M, Björk P, Busch C, Nilsson S.
    Prostate; 1994 Sep 15; 25(3):125-31. PubMed ID: 7520576
    [Abstract] [Full Text] [Related]

  • 18. Study of estramustine binding protein (EMBP): purification of rat EMBP and establishment of RIA.
    Shiina H, Ishibe T, Usui T.
    Biochem Biophys Res Commun; 1989 Dec 29; 165(3):947-55. PubMed ID: 2482024
    [Abstract] [Full Text] [Related]

  • 19. Comparative analysis of prostatic acid phosphatase and prostate-specific antigen mRNA levels in hyperplastic prostate stimulated with steroid hormones and growth factors.
    Dulińska J, Laidler P, Labedź M.
    Acta Biochim Pol; 2002 Dec 29; 49(2):357-68. PubMed ID: 12362977
    [Abstract] [Full Text] [Related]

  • 20. [Measurement of T and DHT contents in normal and diseased human prostate tissues].
    Zhang Y, Ye L, Ding Q, Fang Z, Yao M, Shi D.
    Zhonghua Wai Ke Za Zhi; 2000 Jul 29; 38(7):545-7. PubMed ID: 11832106
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.